Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

KRT17 Antikörper

Der Maus Monoklonal anti-KRT17 Antikörper (Klon KRT17-4604) (ABIN7126633) detektiert spezifisch KRT17 in WB und IHC. Dieser Antikörper reagiert spezifisch mit Proben aus Human.
Produktnummer ABIN7126633
639,45 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 10 Werktagen

Kurzübersicht für KRT17 Antikörper (ABIN7126633)

Target

Alle KRT17 Antikörper anzeigen
KRT17 (Keratin 17 (KRT17))

Reaktivität

  • 168
  • 62
  • 42
  • 20
  • 15
  • 13
  • 6
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 134
  • 43
  • 1
Maus

Klonalität

  • 97
  • 80
  • 1
Monoklonal

Konjugat

  • 89
  • 16
  • 8
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser KRT17 Antikörper ist unkonjugiert

Applikation

  • 126
  • 76
  • 43
  • 37
  • 35
  • 33
  • 27
  • 26
  • 25
  • 16
  • 15
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)

Klon

KRT17-4604
  • Verwendungszweck

    Cytokeratin 17 (CK17) (Basal Epithelial Marker) Antibody

    Spezifität

    Cytokeratin 17 (CK17) is normally expressed in the basal cells of complex epithelia but not in stratified or simple epithelia. Antibody to CK17 is an excellent tool to distinguish myoepithelial cells from luminal epithelium of various glandssuch as mammary, sweat and salivary. CK17 is expressed in epithelial cells of various origins, such as bronchial epithelial cells and skin appendages. It may be considered as epithelial stem cell marker because CK17 Ab marks basal cell differentiation. CK17 is expressed in SCLC much higher than in LADC. Eighty-five percent of the triple negative breast carcinomas immunoreact with basal cytokeratins including anti-CK17. Also important is that cases of triple negative breast carcinoma with expression of CK17 show an aggressive clinical course. Additionally, anti-CK17 and anti-MUC1 immunoreactivity represents pancreatobiliary subtype whereas anti-MUC2 and anti-CDX-2 positivity defines intestinal subtype.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant full-length human KRT17 protein

    Isotyp

    IgG1, kappa
  • Applikationshinweise

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Positive_Control: T24 cells. Human skin, bladder or cervix.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Haltbarkeit

    24 months
  • Target

    KRT17 (Keratin 17 (KRT17))

    Andere Bezeichnung

    KRT17

    Hintergrund

    K17, Keratin Type I Cytoskeletal 17, Keratin-17, KRT17, PCHC1

    Human bladder carcinoma or prostate, A-431 cells

    Molekulargewicht

    46kDa

    Gen-ID

    3872, 2785

    UniProt

    Q04695
Sie sind hier:
Chat with us!